drug
Bio T
Marketedupdated 5mo agoby Teva Pharmaceuticals USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugTestim54 co-mentions · 51 sources
- drugVogelxo54 co-mentions · 51 sources
- drugtestosterone54 co-mentions · 51 sources
- tagRecall45 co-mentions · 44 sources
- tagApproval12 co-mentions · 6 sources
- drugtriamcinolone acetonide ER10 co-mentions · 10 sources
- drugtriamcinolone acetonide Rising10 co-mentions · 10 sources
- drugTRIAMCINOLONE ACETONIDE10 co-mentions · 10 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Bio T
- phase2Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
- phase2Working Out M0 Bipolar Androgen Therapy
- phase2Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
- phase352 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
- phase2Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
- phase2Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- phase4Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
- phase2Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
News(10)
- Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDATwo former FDA commissioners: Heidi Overton is the right pick in a difficult moment.stat · 7d ago
- Opinion: More young men are coming to me for plastic surgery. The way I think about them has changed“The young men in my clinic are responding rationally to a system that was designed for profit,” writes plastic surgeon Kavitha Ranganathan.stat · 11d ago
- This Week at FDA: Overton nomination hearing, FDA’s hiring challenges, and moreThis week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the agency’s hiring challenges, and the agency held two meetings to conside…raps · 11d ago
- Disabled workers at greater risk of losing health insuranceAn organ transplant first, new details on ADA conference controversy, and more health news from Morning Roundsstat · 25d ago
- A new, separate outbreak of the diarrhea-causing parasiteA win for peptide proponents, autism advisory committees clash, and more health news from Morning Roundsstat · 2mo ago
- Expect a clash at today’s FDA peptide panelThe service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news from Morning Roundsstat · 2mo ago
- Opinion: Good riddance to bundled ‘global’ maternal care billingNew maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG writes.stat · 2mo ago
- Opinion: New billing codes likely to raise maternity care costs“This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many other factors raising health insurance premiums,” writes Jeff Levin-Scherz.stat · 2mo ago
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsWhat Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health newsstat · 2mo ago
- Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer“In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new cholesterol drug Lipfendra.stat · 2mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that